← Leaderboards
Bryan M O'Hara
Progenics Pharmaceuticals, Inc.
$600,638
Attributed
$600,638
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$600,638 · 1
By mechanism
R43$600,638 · 1
Top collaborators
No co-investigators on record.
Most similar at Progenics Pharmaceuticals, Inc.
Same institution · by research overlap
- William C Olson$17,385,230
- Glen Andrew Coburn$12,617,543
- Gerald P Donovan$9,061,908
- Paul J Maddon$8,313,643
- Jason Gardner$961,024
Others in their field
Top investigators on “Antiaids Agent”
- Constance Ann Benson · University Of California, San Diego$85,157,000
- Willard Cates · Family Health International$66,963,584
- Stephen A Spector · University Of California, San Diego$62,271,387
- Fred M Gordin · Social And Scientific Systems, Inc.$50,695,408
- Robert Turner Schooley · University Of Colorado Denver$46,857,922
- Douglas D Richman · University Of California San Diego$18,822,170
Research focus
Antiaids AgentAntiviral AgentsChemical Structure FunctionCombinatorial ChemistryDimerDrug Design /Synthesis /ProductionDrug Screening /EvaluationHigh Throughput TechnologyReverse Transcriptase InhibitorsYeast Two Hybrid System